440 results
DCB and latest DES technology for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore the latest in drug-coated balloon (DCB) and drug-eluting stent (DES) technology for coronary interventions. Review predictors of angiographic outcomes, trial data comparing DCB and DES, and insights into treating calcified lesions and bifurcation disease with novel devices.
Transforming PCI: mastering the implementation of drug-eluting balloons
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...
Treating complex CAD indications with sirolimus coated balloon: evidence and performance
22 May 2025 – From EuroPCR 2025
Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...
PCR meets China: great innovations and novel trials
21 May 2025 – From EuroPCR 2025
Join this session to explore innovative coronary and valvular device developments originating from China. Learn about the clinical relevance and global impact of these domestic innovations, and engage in knowledge exchange with Chinese colleagues, celebrating longstanding collaboration in cardiology.
Advancing the standard of care in PCI with Bioadaptor: from simple to complex
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...
How do I confidently expand my drug-coated balloon practice?
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...
New perspectives in 3D calcium visualisation with CT and angiography for complex PCI
21 May 2025 – From EuroPCR 2025
Thanks to this EuroPCR 2025 session, discover new perspectives on 3D calcium visualisation combining advanced imaging techniques like 3DStent, IVUS, and 3D angiography to enhance complex PCI. Learn from detailed calcium mapping and plaque assessment to guide strategic decisions and see these innovations applied in practice...
Pushing boundaries in complex PCIs: unique DES technology for complex lesions and patients
21 May 2025 – From EuroPCR 2025
Explore cutting-edge strategies in complex PCI through four detailed clinical cases: a challenging left main bifurcation, a complex procedure using Guideliner Extension Catheters (GEC), an acute coronary syndrome intervention, and treatment of a patient with high bleeding and ischemic risks. This session demonstrates how thorough patient...
Intracoronary imaging for complex PCI: a must!
21 May 2025 – From EuroPCR 2025
Recognize the indispensable role of intracoronary imaging in managing complex PCI cases. This session explores the evolution of multivessel NSTEMI treatment using DES, BRS, DCB, and imaging, challenges with recurrent in-stent restenosis across multiple stent layers, innovative imaging solutions for complex lesions, and diagnostic approaches to...
Coronary scaffolds: new developments and applications
21 May 2025 – From EuroPCR 2025
Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.
